Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AneuRx Resolves U.S. Field Action, Is Featured In Separate U.K. Device Alert

This article was originally published in The Gray Sheet

Executive Summary

The U.K. Medical Device Agency's most recent medical device alert on Medtronic's AneuRx underscores the importance of anatomical features in deciding whether to treat a patient with the stent graft.
Advertisement

Related Content

FDA Notice Updates Medtronic AneuRx AAA-Related Death Statistics
FDA Notice Updates Medtronic AneuRx AAA-Related Death Statistics
UK Medical Devices Agency Issues AAA, Breast Implant Device Updates
UK Medical Devices Agency Issues AAA, Breast Implant Device Updates
AAA Endovascular Graft Patient Imaging Follow-Up Recommended By FDA
AAA Endovascular Graft Patient Imaging Follow-Up Recommended By FDA
Advertisement
UsernamePublicRestriction

Register

MT014185

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel